Matt Abernethy, Chief Financial Officer at NEUROCRINE BIOSCIENCES INC (NBIX), sold 3,290 shares at $94.66 ($311K) on 2020-12-01, disclosed to the SEC on 2020-12-02.
Open-market sale of $311k NBIX by Chief Financial Officer. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Something here stands out, but not much.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $94.66 | 1,645 | $156K | 50.0% |
| 2 | $94.66 | 1,645 | $156K | 50.0% |
| Total | $94.66 avg | 3,290 | $311K | 100% |
| Filing → |
| NBIX | SELL | 2025-02-12 | $232K | — | Filing → |
| NBIX | SELL | 2025-02-04 | $392K | — | Filing → |
| NBIX | SELL | 2024-08-15 | $2.1M | — | Filing → |